University of Ottawa Medical Oncology Training Program

Retweeted An Evening of Hope ():

The Faces of Lung Cancer Wall has become a popular feature at our event. If you you would like to include a photo of yourself or a loved one for this year’s Faces of Lung Cancer Wall, please send a high resolution photo – before October 20 – to [email protected] https://t.co/CFXBC7bflr

Retweeted Neil Reaume MD ():

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study https://t.co/jEIwYdqwwQ

Retweeted Neil Reaume MD ():

VISION phase 3 177Lu-PSMA-617 In mCRPC post chemotherapy

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Full Text View - ClinicalTrials.gov Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Full Text View.

Gr8 to see alumnus making us proud. Keep sending updates!

Shaan Dudani on Twitter “A few from my first couple days in Thimphu! Looking forward to a productive month at JDWNRH with ”

Thanks, you are the best!

Tina Hsu on Twitter “Use of enzalutamide in pt with rising PSA but no Mets decreases metastasis free survival - appropriate endpoint? https://t.co/TW9ZIrIvP2”

Retweeted Neil Reaume MD ():

Met Free Survival in Prostate Ca NEJM

Metastasis-free Survival — A New End Point in Prostate Cancer Trials | NEJM Perspective from The New England Journal of Medicine — Metastasis-free Survival — A New End Point in Prostate Cancer Trials

Also welcome to clinical research fellows Drs Awan, Bassulaiman & ( veteran) Hernandez-Torres

Proud to welcome new residents Drs Al Saadi, Al Shareef & Pauls... our first cohort of trainees using

Retweeted Paul Wheatley-Price ():

With at the airport as he leaves for home after 2 year fellowship in GI and lung cancer Waleed, you are the definition of a gentleman and you enriched our program. Thank you and Bon Voyage https://t.co/99N178VERE

Retweeted Tina Hsu ():

presents a compelling case to the Dragon’s Den for a change to the Canadian drug approval process https://t.co/uNeR2YG4dF

Congrats . Well deserved. Now get back to work!

Dominick Bossé, MD MPH on Twitter “Honored and grateful to be one of the Conquer Cancer Merit Award recipients among so many amazing researchers at this year conference. Thanks and mentor https://t.co/Sx3BuWlUmC”

Retweeted Tina Hsu ():

Great start to Lucky to work with such a great group of colleagues and residents! rocks!!! https://t.co/5O4jdbAee6